Go Ad-Free
    My Alerts
    VICTORIS
    Budget Express 2026

    co-presented by

    • LIC
    • JIO BlackRock

    ASSOCIATE SPONSORS

    • Sunteck
    • SBI
    • Emirates
    • Dezerv
    Loans
    Loans
    HomeNewsBusinessEarningsRanbaxy likely to post PAT at Rs 140 cr in Q3

    Ranbaxy likely to post PAT at Rs 140 cr in Q3

    Pharmaceutical firm Ranbaxy Labs is expected to report a profit after tax of Rs 140 crore in the third quarter of 2011 as against Rs 308 crore in a year ago period.

    November 09, 2011 / 09:11 IST

    Pharmaceutical firm Ranbaxy Labs is expected to report a profit after tax of Rs 140 crore in the third quarter of 2011 as against Rs 308 crore in a year ago period.

    Revenues are seen going up 8% to Rs 2,091 crore versus Rs 1,935 crore during the same period.

    EBITDA is likely to jump 28% to Rs 177 crore in July-September quarter of 2011 versus Rs 139 crore in the corresponding quarter of last fiscal.

    Operating profit margin is expected to be at 8.5% versus 7% year-on-year. 

    Important quarter for Ranbaxy

    first published: Nov 9, 2011 07:26 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347